Targeting miR-155 to Treat Experimental Scleroderma

Targeting miR-155 to Treat Experimental Scleroderma

Item
http://www.wikidata.org/entity/Q36524910
The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosisMir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis.A comparative study of the characterization of miR-155 in knockout mice.miR-155 in the progression of lung fibrosis in systemic sclerosis.Interfacial Adipose Tissue in Systemic Sclerosis.Unfolding the pathogenesis of scleroderma through genomics and epigenomics.Morphea and Eosinophilic Fasciitis: An Update.MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.Epigenetic factors as drivers of fibrosis in systemic sclerosis.Inflammasome lights up in systemic sclerosis.Epigenetics: The Future Direction in Systemic Sclerosis.AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis.Casein kinase 1α: biological mechanisms and theranostic potential.Epigenetic Regulation of Myofibroblast Phenotypes in Fibrosis
P2860

Targeting miR-155 to Treat Experimental Scleroderma

Item
http://www.wikidata.org/entity/Q36524910
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting miR-155 to Treat Experimental Scleroderma
@ast
Targeting miR-155 to Treat Experimental Scleroderma
@en
type
label
Targeting miR-155 to Treat Experimental Scleroderma
@ast
Targeting miR-155 to Treat Experimental Scleroderma
@en
prefLabel
Targeting miR-155 to Treat Experimental Scleroderma
@ast
Targeting miR-155 to Treat Experimental Scleroderma
@en
P1433
P1476
P2093
P2507
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Targeting miR-155 to Treat Experimental Scleroderma
@en
P2093
P2507
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932